LumediX has developed a technology that increases the sensitivity of currrent immunoassais by a factor of 100 to 1000, making a lab-grade diagnostic possible in point-of-care formats in the field during emergencies, or in places with low medical infrastructure for everyone, everywhere, any time.

Restez informés sur l’actualité de Paris-Saclay SPRING 2019 !

* Requis